Name: Latest research reports of Biocon Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Axis Direct

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

368.9000 -3.20 (-0.86%)

NSE Jul 08, 2025 15:30 PM

26.77% Gain from 52W Low

Volume: 2.5M

Biocon Ltd.

24 Jan 2022

368.90

-0.86%

Result Update:Biocon

Buy: Biocon Ltd.

Target

Axis Direct

Therefore, we recommend a BUY rating with a Target Price of Rs 425, implying an upside of 14% from the CMP.

Number of FII/FPI investors increased from 297 to 305 in Mar 2025 qtr.